inVentiv Health is expanding its adoption of the Veeva Vault Clinical Suite by adopting Veeva Vault Study Startup, which is designed to accelerate document-intensive site activation and speed time to first patient enrollment.
 
Vault Study Startup aims to help inVentiv streamline complex activities related to site activation, including ethics committee and Ministry of Health submissions and approvals, document distribution and tracking, and site contract transactional activities. inVentiv aims to improve the efficiency of trial processes by managing documents, data, and study start-up activities on a single cloud platform, as well as provide stakeholders access to the same, up-to-date clinical information for improved collaboration. Also, interoperability between Vault Study Startup and Vault eTMF helps to ensure that documents and data are available in both applications.
 
“We recognized the value an innovative technology solution could have in knocking down hurdles that slow progress during the study start-up phase, where improvements can have a significant impact on overall trial results,” said Rachel Stahler, CIO, inVentiv Health. “inVentiv identified Veeva as a best-of-breed platform that can maximize efficiencies and accelerate the delivery of much needed drugs to patients.”